Non-Hodgkin's Lymphoma

罗氏肿瘤
... anti-CD22 antibody, epratuzumab, in combination with rituximab, in
refractory or recurrent non-Hodgkin's lymphoma. ... Cancer Research United
Kingdom Medical Oncology Unit, St Bartholomew's Hospital, London, United
Kingdom. ...
<http://www.rocheoncology.com.cn/news/b_view.asp?id=723>

ProMACE/CytaBOM方案治疗中高度非霍奇金淋巴瘤-中国护士生活网-护理 ...
（Wanjie Hospital of Shandong Zibo, Zibo 255213）. 【Abstract】
Objective：Evaluation of clinical response and toxic effects of
ProMACE/CytaBOM in non-Hodgkin's lymphoma.Methods：Among the 34 patients,
there were 21 cases of diffuse ...
<http://www.nurselife.cn/Html/zlx/2007073554.html>

复旦大学附属肿瘤医院上海市肿瘤医院-学科建设-中国癌症杂志-过刊下载 ...
XU Bing-he (Cancer Hospital and Institute, Chinese Academy of Medical
Sciences & Peking Union Medical College, ...... Comparison of DICE and CHOP
regimen in the treatment of intermediate and high grade Non-Hodgkin's
lymphoma-a clinical ...
<http://www.shca.org.cn/index.php?id=427>

此 出现新的结果时 Google 快讯由 Google 提供...
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
取消此 Google 快讯:
http://www.google.com/alerts/remove?s=EAAAAKA_49sQvZz9q2PZw36rT_k&hl=zh-CN

创建另一个 Google 快讯:
http://www.google.com/alerts?hl=zh-CN

登录以管理快讯:
http://www.google.com/alerts/manage?hl=zh-CN